Xtx Topco LTD Paratek Pharmaceuticals, Inc. Transaction History

Xtx Topco LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.52 - $2.8 $95,665 - $176,226	62,938 New	62,938 $139,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $29,854 - $44,871	17,877 Added 28.6%	80,387 $150,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $86,810 - $129,772	44,291 Added 243.1%	62,510 $161,000
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $29,591 - $52,854	-17,105 Reduced 48.42%	18,219 $35,000
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $26,092 - $42,333	8,875 Added 33.56%	35,324 $105,000
Q4 2021 Feb 11, 2022	BUY	$4.07 - $5.3 $46,935 - $61,119	11,532 Added 77.31%	26,449 $119,000
Q3 2021 Nov 12, 2021	BUY	$4.7 - $7.24 $70,109 - $107,999	14,917 New	14,917 $72,000
Q2 2021 Aug 12, 2021	SELL	$6.81 - $10.93 $105,044 - $168,595	-15,425 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$6.14 - $8.31 $94,709 - $128,181	15,425 New	15,425 $109,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.